Strategic Wealth Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Strategic Wealth Partners's ELV Position: Q1 2026 in Review
Strategic Wealth Partners reduced its Elevance Health (ELV) stake by 35% in Q1 2026, selling an estimated $81.2K and leaving 458 shares worth $134K. The position accounts for 0.01% of the portfolio, ranked #355.
Strategic Wealth Partners first reported a position in ELV in Q2 2018 and has held it in 19 quarters since. The position peaked at $3.7M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Strategic Wealth Partners held 458 shares of Elevance Health worth $134K as of Q1 2026.
- Strategic Wealth Partners sold 247 Elevance Health shares in Q1 2026, an estimated $81.2K.
- Elevance Health made up 0.01% of Strategic Wealth Partners's portfolio in Q1 2026, its #355 holding.
- Strategic Wealth Partners first reported a position in Elevance Health in Q2 2018 and has held it in 19 quarters since.
- Strategic Wealth Partners's Elevance Health position peaked at $3.7M in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Strategic Wealth Partners's 13F filing for Q1 2026, filed 12 May 2026.